British HIV Association
| Abbreviation | BHIVA |
|---|---|
| Established | 1995 |
| Location | |
Chair | Yvonne Gilleece |
| Website | www.bhiva.org |
The British HIV Association (BHIVA) is an organisation of healthcare professionals interested in the treatment and care of people with HIV.
The current BHIVA Chair is Prof. Yvonne Gilleece.[1]
The aims of BHIVA are, to advance:
- Promotion of good practice in the treatment of HIV
- Public education through the promotion and dissemination of research[2]
Conferences
BHIVA holds two national conferences per year, the BHIVA National Conference in April and the BHIVA Autumn Conference.[3]
Guidelines
BHIVA produce guidelines which are accredited by the UK National Institute for Health and Care Excellence (NICE).[4]
Guidelines produced by BHIVA include:
- Pre-exposure prophylaxis (PrEP) guidelines[5]
- Treatment of HIV-1 positive adults[6]
- Use of Vaccines in HIV-positive adults[7]
- Post-exposure prophylaxis (PEP) guidelines[8]
- Opportunistic infection in HIV-positive individuals[9]
See also
References
- ^ "Executive Committee". www.bhiva.org. Retrieved 2020-04-19.
- ^ Orkin, Chloe. "Kings Fund Concluding Remarks" (PDF). www.kingsfund.org.uk. Retrieved 12 September 2017.
- ^ i-base (12 September 2017). "i-base Future Meetings". i-base.
- ^ NICE (12 September 2017). "NICE Accreditation Decisions".
- ^ Brady, Michael; et al. (14 March 2019). "BHIVA/BASHH guidelines on the use of HIV pre–exposure prophylaxis (PrEP) 2018". HIV Medicine. 20 (S2): s2 – s80. doi:10.1111/hiv.12718. PMID 30869189.
- ^ Churchill, Duncan; et al. (17 Aug 2016). "British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015" (PDF). HIV Medicine. 17 (s4): s2 – s104. doi:10.1111/hiv.12426. PMID 27568911. S2CID 32394203.
- ^ Geretti, AM; et al. (17 Aug 2016). "British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015" (PDF). HIV Medicine. 17 (s3): s2 – s81. doi:10.1111/hiv.12424. PMID 27568789. S2CID 142893.
- ^ Cresswell, Fiona; et al. (27 Aug 2016). "UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure, 2015" (PDF). Int J STD AIDS. 27 (9): 713–38. doi:10.1177/0956462416641813. PMID 27095790. S2CID 33255206.
- ^ Nelson, M; et al. (Sep 2011). "British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011". HIV Medicine. 12 (S2): 1–140. doi:10.1111/j.1468-1293.2011.00944_1.x. PMID 21851517. S2CID 22513510.
